South America News
Found 1,348 articles
Ironshore Pharmaceuticals & Development, Inc., today announced that the U.S.Food and Drug Administration has accepted the resubmission of the New Drug Application for HLD200, Ironshore’s lead compound currently under review as a new treatment for Attention Deficit Hyperactivity Disorder and set a Prescription Drug User Fee Act date of August 8, 2018.
Genomma Lab will report Second Quarter 2018 results on Wednesday, July 25, 2018 after the Mexican Market close.
Andrew Huberman, researcher in the Stanford University Department of Neurobiology, is taking an unusual approach to investigating possible treatments for glaucoma and anxiety disorders—virtual reality.
Genomma Lab Announces Acquisition of Bufferin®, Cheracol D® and Rose Milk® Brands - Expands OTC Offerings in the U.S.
Genomma Lab Internacional, S.A.B. de C.V. announced it has purchased three over-the-counter (OTC) brands in the United States, in two separate transactions as part of its strategy to strengthen its presence in the U.S. branded consumer health market.
Injured veterans and their significant others recently enjoyed an evening of romance and camaraderie at a Wounded Warrior Project® (WWP) Physical Health and Wellness event at Leñas Café.
Centro de Imagem Diagnósticos S.A. ("Alliar" or "Company") (B3: AALR3), announces today its results for the first quarter of 2018 (1Q18).
DOUBLE-DIGIT REVENUE AND EBITDA GROWTH. ALL MARGINS IMPROVING SIGNIFICANTLY. NEW PRODUCTS LAUNCHES AHEAD OF PLAN. EXTENDED PARTNERSHIP WITH GILEAD INTO ANDEAN REGION.
PharmaCielo Ltd. is pleased to announce its partnership with the Universidad CES, one of Colombia's leading educational and research institutions, to deliver a series of cannabinoid education symposiums to medical practitioners, resulting in academic accreditation.
Elekta further invests in Mexico with new offices and fortified workforce [09-April-2018] Elekta Strengthens Presence in Mexico With Government Tender for Radiation Therapy Technology Elekta further invests in Mexico with new offices and fortified workforce MEXICO, April 9, 2018
Centro de Imagem Diagnósticos SA announces its results for the fourth quarter of 2017 (4Q17).
Biotoscana Investments S.A. announced its results for the 4Q17 and full year of 2017.
Laboratorio Noy Launches Novel PD-L1 Assay for Bladder Cancer Based on IncellDx’s Single Cell Immuno-Oncology/PD-L1 Technology
Laboratorio Noy (Lab Noy) announced today the launch of Oncocyst PD-L1, an assay using IncellDx technology that quantifies the percentage of abnormal bladder cells and immune cells from urine cytology specimens that express the immune-oncology marker PD-L1 using multi-parameter flow cytometry including cell cycle.
Eurofarma Group Release: Unprecedented Project in Brazilian Industry Has an Investment of R$ 8.4 Million
Embrapii will finance R$ 1.8 million per company with non-refundable resources, that is, without the need to refund the amount.
Grunenthal to Distribute, Promote, and Sell MSD's Women's Health Products in Several Countries in Latin America
Gruenenthal announced today that it has entered into a distribution agreement with MSD for distributing, promoting and selling MSD's Women's Health products in Brazil, Central America, Colombia, Mexico and Peru.
FuturaGene's Exclusive License for RNAi Technology in Eucalyptus Enhanced by Grant of Patent in Brazil
FuturaGene and Australia's CSIRO are pleased to announce that a patent has been issued in Brazil to CSIRO, which covers the downregulation of the expression of plant target genes or other target genes
Henry Schein Acquires Majority Interest in ABASE, a Distributor of Veterinary Health Care Products in Sao Paulo, Brazil
Henry Schein announced today that it has acquired a 60 percent ownership investment in ABASE.
IBA Signs Contract for Additional Treatment Capacity at Latin America's First Proton Therapy Center In Argentina
IBA expects to receive a down payment for this new contract in the coming weeks.
Biocon and Mylan's Biosimilar Trastuzumab Receives Approval From ANVISA, Brazil Through Their Partner Libbs
Libbs will commercialize the product in Brazil under the brand name Zedora, which will provide affordable access to a cutting-edge biologics therapy for patients in Brazil.
Venus Medtech Release: First Successful Clinical Implantation of Transcatheter Pulmonary Valve VenusP-Valve was Successfully Completed in Brazil
On December 19, 2017, local time, 4 clinical implantations of transcatheter pulmonary valve VenusP-Valve were successfully completed in Brazil by Professor Carlos Pedra from Dante Pazzanese Institute of Cardiovascular Technology in Sao Paulo, Brazil.
This registration allows Varian to market this new system in Brazil.